- Home
- WLK vs ICLR Comparison
WLK vs ICLR Comparison
Compare WLK & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WLK
- ICLR
- Stock Information
- Founded
- WLK 1986
- ICLR 1990
- Country
- WLK United States
- ICLR Ireland
- Employees
- WLK N/A
- ICLR N/A
- Industry
- WLK Major Chemicals
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- Sector
- WLK Industrials
- ICLR Health Care
- Exchange
- WLK Nasdaq
- ICLR Nasdaq
- Market Cap
- WLK 14.6B
- ICLR 16.4B
- IPO Year
- WLK 2004
- ICLR 1998
- Fundamental
- Price
- WLK $109.75
- ICLR $201.39
- Analyst Decision
- WLK Buy
- ICLR Strong Buy
- Analyst Count
- WLK 14
- ICLR 12
- Target Price
- WLK $153.64
- ICLR $278.27
- AVG Volume (30 Days)
- WLK 605.3K
- ICLR 913.3K
- Earning Date
- WLK 02-24-2025
- ICLR 02-19-2025
- Dividend Yield
- WLK 1.91%
- ICLR N/A
- EPS Growth
- WLK N/A
- ICLR 28.78
- EPS
- WLK 0.74
- ICLR 9.53
- Revenue
- WLK $12,125,000,000.00
- ICLR $8,281,675,999.00
- Revenue This Year
- WLK N/A
- ICLR $4.00
- Revenue Next Year
- WLK $4.61
- ICLR $1.37
- P/E Ratio
- WLK $147.30
- ICLR $21.18
- Revenue Growth
- WLK N/A
- ICLR 1.99
- 52 Week Low
- WLK $108.56
- ICLR $181.51
- 52 Week High
- WLK $162.64
- ICLR $347.72
- Technical
- Relative Strength Index (RSI)
- WLK 40.12
- ICLR 54.92
- Support Level
- WLK $110.31
- ICLR $181.51
- Resistance Level
- WLK $114.09
- ICLR $203.26
- Average True Range (ATR)
- WLK 2.70
- ICLR 6.32
- MACD
- WLK 0.01
- ICLR 1.50
- Stochastic Oscillator
- WLK 12.31
- ICLR 72.45
About WLK Westlake Corporation
Westlake Corp is a manufacturer and supplier of chemicals, polymers and building products. Its Performance and Essential Materials segment offers a wide range of essential building blocks for making products utilized in everyday living, including olefins, vinyl chemicals, polyethylene, and epoxies. Its Housing and Infrastructure Products segment produces key finished goods for building products, pipe and fittings, and global compounds businesses.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.